4.2 Article

A very mild phenotype in six individuals of a three-generation family with the novel HRAS variant c.176C > G p.(Ala59Gly): Emergence of a new HRAS-related RASopathy distinct from Costello syndrome

Journal

AMERICAN JOURNAL OF MEDICAL GENETICS PART A
Volume 191, Issue 8, Pages 2074-2082

Publisher

WILEY
DOI: 10.1002/ajmg.a.63240

Keywords

attenuated phenotype; Costello syndrome; HRAS; HRAS-related RASopathy; loose anagen hair; p; Ala59Gly; RASopathy

Ask authors/readers for more resources

Costello syndrome is a severe neurodevelopmental disorder caused by activating variants in HRAS. We report a unique and attenuated phenotype in six individuals with the HRAS variant c.176C>T p.(Ala59Gly), which has not been reported before as a germline variant. These individuals show ectodermal anomalies and mild features of a RASopathy, similar to patients with a Noonan syndrome-like disorder. Our findings suggest a distinct HRAS-related RASopathy for patients carrying HRAS variants affecting codons 58, 59, 60.
Costello syndrome is a clinically recognizable, severe neurodevelopmental disorder caused by heterozygous activating variants in HRAS. The vast majority of affected patients share recurring variants affecting HRAS codons 12 and 13 and a relatively uniform phenotype. Here, we report the unique and attenuated phenotype of six individuals of an extended family affected by the HRAS variant c.176C>T p.(Ala59Gly), which, to our knowledge, has never been reported as a germline variant in patients so far. HRAS Alanine 59 has been previously functionally investigated as an oncogenic hotspot and the p.Ala59Gly substitution was shown to impair intrinsic GTP hydrolysis. All six individuals we report share a phenotype of ectodermal anomalies and mild features suggestive of a RASopathy, reminiscent of patients with Noonan syndrome-like disorder with loose anagen hair. All six are of normal intelligence, none have a history of failure to thrive or malignancy, and they have no known cardiac or neurologic pathologies. Our report adds to the previous reports of patients with rare variants affecting amino acids located in the SWITCH II/G3 region of HRAS and suggests a consistent, attenuated phenotype distinct from classical Costello syndrome. We propose the definition of a new distinct HRAS-related RASopathy for patients carrying HRAS variants affecting codons 58, 59, 60.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available